An exciting, futuristic chapter for clinical trials has opened in which participant engagementwill flourish, expansive data will navigate the maze of disease and digital technology will take pharma and patients to previously unexplored dimensions.
Communication between pharma, patients and wider healthcare has helped to create a solid foundation upon which the general public understands disease and, crucially, trusts emerging therapies. Now that vaccines promise a ‘way out’ of th
Successful treatment development relationships rely on the ability of contract research organisations to bring their skills to the table – and pharma’s willingness to let that happen - Magazine Article - PharmaTimes
Sales in pharma is a frequently changing canvass. Its leveraging of technology has triggered new, bold approaches, while also upholding a fine tradition of individuality among its multifarious and talented workforce. Finding the most compelling mix
Across the pharma industry and throughout healthcare, the totems of difference and parity provide genuine opportunities for tangible change. Improved outcomes, a greater understanding of the human condition and an environment which includes everyone
To understand the full scope of a condition, pharma needs to appreciate the full tapestry of the patient experience. The challenge for industry in the realm of rare diseases, however, is to meaningfully engage with patients and convince them that
It’s the start of a glorious new decade for pharma. As the advances in medtech, gadgets and innovation jump into hyperspace, a completely rebooted pharmaverse awaits us. The new era offers the chance to inspire and define, while navigating it